Research in inflammatory bowel disease in Brazil: a step forward towards patient care

Kotze, Paulo Gustavo; Damião, Adérson Omar Mourão Cintra

doi:10.1590/s0004-2803.202000000-43

Cited by 2 publications

(4 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Growing rates are also observed in Latin American countries. In Brazil, for example, in some regions the UC:CD ratio presents a distribution similar to that of countries in North America and Europe when compared to some countries in Latin America (14,29) .…”

Section: Discussionmentioning

confidence: 91%

“…Kamila Rosa MARTINS 1,2 , Joniel Mendes de ARAÚJO 2 , Álefe Cardoso CRUZ 2 and Anderson LUIZ-FERREIRA 2 tries (13) , with higher occurrence in the Northern hemisphere (14,15) . However, the incidence has also increased in regions where these diseases were previously considered of low prevalence, such as Japan, South Korea, Singapore, Northern India, and Latin America (16) .…”

Section: Epidemiologic Aspects Of Inflammatory Bowel Disease In the W...mentioning

confidence: 99%

See 1 more Smart Citation

Epidemiologic Aspects of Inflammatory Bowel Disease in the Western Region of Minas Gerais State

Martins

Araujo²,

Cruz³

et al. 2021

Arq. Gastroenterol.

View full text Add to dashboard Cite

BACKGROUND: Crohn’s disease (CD) and ulcerative colitis (UC), two of the main inflammatory bowel diseases (IBD), have been increasingly diagnosed in South America. Although IBD have been intensively studied in the last years, epidemiologic data in Brazil are scarce. OBJECTIVE: To study the clinical and epidemiologic profile of IBD patients treated in the Clinical Hospital of the Federal University of Uberlândia from 1999 to 2014. METHODS: We performed a retrospective study of the medical records of patients diagnosed with IBD, according to the international classification of diseases (ICD) - ICD K50 for CD and ICD K51 for UC - confirmed by endoscopic examination in the case of both diseases. We analyzed the following variables: age; sex; ethnicity; smoking habit; primary diagnosis; site of disease manifestation; main clinical manifestations; IBD-related complications; extraintestinal manifestations; and established drug and/or surgical treatment. RESULTS: We evaluated 183 IBD cases (91 UC and 92 CD cases). The estimated prevalence rate of UC was 15.06/100.000 inhabitants and of CD was 15.23/100.000. The CU and CD female to male incidence ratios were 1.7 and 1.8, respectively. The average age of patients diagnosed with UC was 39.4 years and of those diagnosed with CD was 31.1 years. White-skinned people were the most affected by UC (66.0%) and CD (69.0%). Few patients were submitted to surgical procedures as treatment alternative. CONCLUSION: The estimated prevalence of IBD in this population was low compared to that of populations of North America, but high compared to that of other regions considered to present low incidence, such as some Asian and Latin American countries.

show abstract

Section: Discussionmentioning

confidence: 91%

Section: Epidemiologic Aspects Of Inflammatory Bowel Disease In the W...mentioning

confidence: 99%

Epidemiologic Aspects of Inflammatory Bowel Disease in the Western Region of Minas Gerais State

Martins

Araujo²,

Cruz³

et al. 2021

Arq. Gastroenterol.

View full text Add to dashboard Cite

show abstract

“…The incidence rates of UC and CD in Brazil are now similar to those in North America and Europe. 2 These diseases mainly affect young individuals and, because they are chronic and recurrent, they lead to structural damage that compromises quality of life and increases morbidity and mortality. Despite advances in clinical treatment, including new drugs with new mechanisms of action, surgery still plays an important role in the management of these diseases.…”

Section: Introductionmentioning

confidence: 99%

“…The probability that a patient with CD will have to undergo a surgical procedure during the first 10 years of the disease is 50%. 2 In patients with UC, the cumulative 5- to 10-year risk of colectomy is 10–15%, mainly in patients with moderate to severe activity. 3 Predictors of severity include early age (< 40 years) at diagnosis, extensive disease, severe endoscopic activity (large and/or deep ulcers), extraintestinal manifestations, early need for corticosteroids, and high inflammatory markers, among others.…”

Section: Introductionmentioning

confidence: 99%

Profile of Surgeons Who Treat Inflammatory Bowel Diseases in Brazil

Zabot,

Cassol,

Vilela

et al. 2024

Journal of Coloproctology

View full text Add to dashboard Cite

Objective To describe the profile of surgeons who treat patients with inflammatory bowel disease as well as the characteristics of inflammatory bowel disease care, unmet demands, and difficulties. Methods The research participants answered a Google Forms questionnaire. Results Of the 99 surgeons who participated in the survey, 84.5% were coloproctologists, 40% were from the southeastern region of Brazil, and 77.7% were male and had been working for more than 19 years. Regarding the healthcare sector, 63.6% of surgeons worked in both public and private clinics, and most clinically cared for up to 50 patients with inflammatory bowel disease and operated on up to 5 cases per year. Conclusion This is the first national study that aimed to identify the profile of surgeons working with inflammatory bowel disease in Brazil. The vast majority are experienced male coloproctologists, located in the southern and southeastern regions, who perform clinical and surgical treatment of these pathologies, with major surgeries being performed in large centers by a small number of surgeons.

show abstract

Research in inflammatory bowel disease in Brazil: a step forward towards patient care

Cited by 2 publications

References 22 publications

Epidemiologic Aspects of Inflammatory Bowel Disease in the Western Region of Minas Gerais State

Epidemiologic Aspects of Inflammatory Bowel Disease in the Western Region of Minas Gerais State

Profile of Surgeons Who Treat Inflammatory Bowel Diseases in Brazil

Contact Info

Product

Resources

About